Correlation Between Vir Biotechnology and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vir Biotechnology and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Vir Biotechnology and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Hepion Pharmaceuticals.
Diversification Opportunities for Vir Biotechnology and Hepion Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vir and Hepion is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vir Biotechnology and Hepion Pharmaceuticals
Considering the 90-day investment horizon Vir Biotechnology is expected to generate 0.79 times more return on investment than Hepion Pharmaceuticals. However, Vir Biotechnology is 1.26 times less risky than Hepion Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 1,063 in Vir Biotechnology on August 31, 2024 and sell it today you would lose (277.00) from holding Vir Biotechnology or give up 26.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vir Biotechnology vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Vir Biotechnology |
| Hepion Pharmaceuticals |
Vir Biotechnology and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vir Biotechnology and Hepion Pharmaceuticals
The main advantage of trading using opposite Vir Biotechnology and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
| Hepion Pharmaceuticals vs. Cue Biopharma | Hepion Pharmaceuticals vs. Eliem Therapeutics | Hepion Pharmaceuticals vs. Inhibrx | Hepion Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |